Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.30
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.10 (7.692%)
Open: 1.35
High: 1.375
Low: 1.35
Prev. Close: 1.35
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

Tue, 26th May 2020 14:22

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

Matomy Media Group Ltd - media technology - Appoints Amitay Weiss as chair. Says Chief Financial Officer Ilan Tamir to be interim CEO as well as CFO before leaving the company on September 30. The Tel Aviv-based company's brief announcement didn't provide any further details about the two management changes. Back in February, Matomy said Sami Totah, chair since June 2018, had resigned following the sale of the 9.5% stake in Matomy held by Viola AV Adsmarket LP, where Totah is general partner. In March, as Matomy reported a widened loss for 2019, CFO Tamir said: "We are glad to have brought Matomy to safe harbours. We were successful in selling Team Internet, which enabled us to redeem the bond, and pay off all of the company's debts." In December of last year, Matomy agreed to sell its 90% stake in Team Internet, which provides services in the direct navigation search market, to CentralNic Group PLC.

----------

Shield Therapeutics PLC - iron deficiency treatments - Hans Peter Hasler to become non-executive chair from annual general meeting on June 18, replacing James Karis. Hasler joined the Shield Therapeutics board in July 2018. He was COO of Elan Corp and of Biogen Inc.

----------

SQN Secured Income Fund PLC - secured lending income investment - Chair Ken Hillen steps down as a director, citing a potential conflict between his business interests and those of the investment trust in the near term. Hillen was named chair at the end of 2018. David Stevenson steps up to chair from Tuesday. Stevenson has been a director since 2015.

----------

Bank of Cyprus Holdings PLC - universal banking - Takis Arapoglou re-elected as chair. Lyn Grobler is elected vice-chair, succeeding Maksim Goldman.

----------

PureTech Health PLC - clinical-stage biotherapeutics - Vor Biopharma, a company founded by PureTech Health, names Nathan Jorgensen as chief financial officer. Jorgensen has worked in healthcare-focused finance roles at Qatar Investment Authority and Stifel Nicolaus.

----------

Dev Clever Holdings PLC - cloud-based gamification and virtual reality - Adds Chief Operating Officer Tim Heaton to board, with immediate effect. Heaton joined Dev Clever back in October, having been business development director for Europe, Middle East and Africa at Oracle Corp. Heaton has been leading Dev Clever's efforts to integrate its educational careers guidance software applications with a hardware manufacturer. This recently resulted in a three-year exclusive contract with China's Lenovo Group Ltd.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
13 Sep 2018 11:51

Shield Therapeutics Completes Recruitment For Feraccru Trial

LONDON (Alliance News) - Shield Therapeutics PLC said on Thursday it has completed recruitment of patients for the AEGIS-H2H Phase 3b study of oral Feraccru in subjects suffering from inflammatory

Read more
26 Jul 2018 13:05

Shield Therapeutics Appoints Hans-Peter Hasler To Board

LONDON (Alliance News) - Shield Therapeutics PLC, a commercial stage pharmaceutical company, said Thursday that it has appointed Hans-Peter Hasler as non-executive director with immediate is the a

Read more
20 Jun 2018 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 21 JuneHSS Hire GroupFriday 22 JuneCambian Fifteen Communications Shipping 25

Read more
14 Jun 2018 13:48

Shield Therapeutics Reports Positive Results From Feraccru Study

LONDON (Alliance News) - Pharmaceutical company Shield Therapeutics PLC said Thursday it has had positive top-line results from its paediatric phase I pharmacokinetics study of its ferric iron is

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
6 Jan 2017 08:12

Shield Therapeutics sees 'encouraging' demand for oral iron product in England, Germany

(ShareCast News) - AIM-listed pharmaceutical Shield Therapeutics saw "encouraging" demand for its oral iron product in the England and Germany. The company said is seeing "very encouraging signals of demand" after only six months since the commercial launch of Feraccru, which treats of iron deficien

Read more
14 Jun 2016 09:17

Shield Therapeutics Reports Widened Pretax Loss In Maiden 2015 Results

Read more
7 Jun 2016 15:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
26 Feb 2016 09:17

Shield Therapeutics Starts Trading, Gets European Feraccru Approval (ALLIPO)

Read more
12 Feb 2016 11:50

Shield Therapeutics Raises GBP32.5 Million In Delayed AIM IPO (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.